This study aims to evaluate the incremental value of plasma biomarkers to traditional clinical variables for risk stratification of 30-day and one-year mortality in acutely decompensated heart failure (ADHF).

Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study

METRA, Marco;
2014-01-01

Abstract

This study aims to evaluate the incremental value of plasma biomarkers to traditional clinical variables for risk stratification of 30-day and one-year mortality in acutely decompensated heart failure (ADHF).
2014
Esperti anonimi
Inglese
Internazionale
168
3
2186
2194
9
ADHF; Biomarkers; Mortality; Reclassification; Risk prediction; Acute Disease; Aged; Aged, 80 and over; Biological Markers; Cause of Death; Female; Follow-Up Studies; Global Health; Heart Failure; Humans; Male; Predictive Value of Tests; Risk Factors; Survival Rate; Risk Assessment
22
info:eu-repo/semantics/article
262
Lassus, Johan; Gayat, Etienne; Mueller, Christian; Peacock, W. Frank; Spinar, Jindrich; Harjola, Veli Pekka; van Kimmenade, Roland; Pathak, Atul; Muel...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11379/457667
Citazioni
  • ???jsp.display-item.citation.pmc??? 78
  • Scopus 219
  • ???jsp.display-item.citation.isi??? 190
social impact